Post-earnings recap
Reported
Mon, Feb 4, 2008
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Illumina's earnings report showed a strong EPS beat, indicating better-than-expected profitability. However, the stock fell by nearly 4%, likely due to a lack of revenue details and forward guidance. Investors may be cautious given the absence of specific future expectations from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.38 | N/A | +55.74% |
| Revenue | N/A | N/A | N/A |
Management expressed confidence in the company's position within the industry. However, they did not provide any forward-looking guidance.
Management highlighted strong performance in the genomic sequencing market.
They noted ongoing investments in research and development.
No specific guidance was provided for future quarters.